Thi Huong Lan Do^1,2*, Caroline Lohoff^3,4*, Ferris Jung^5*, Sandra Kummer^1*, Vladimir Benes^5*, Wolfgang Huber^4*, Junyan Lu^4,6* and Thorsten Zenz^1,2,7

¹Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
²University of Zurich (UZH), Zurich, Switzerland
³Medical Faculty Heidelberg, Heidelberg University Hospital, Heidelberg, Germany
⁴Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany
⁵Genomic Core Facility, European Molecular Biology Laboratory, Heidelberg, Germany
⁶Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany
⁷INTeRCepT Consortium, The LOOP Zurich Medical Research Center, Zurich, Switzerland

Hélène Duparc, PhD^1*, James Neef, BS^2*, Janany Kandiah, MS^1*, Maulasri Bhatta, PhD^2*, Agathe Chédeville, PhD^1*, Joe DeBartolo, PhD^2*, Sara Sinicropi-Yao, PhD^2*, Betty Chan, PhD^2*, Alex Constan, PhD^2*, Christophe Marzac, MD^1*, Jean-Baptiste Micol, MD^1,3, Laura Antipov, PhD^2*, Stephane De Botton^1*, Katharine E Yen, PhD², David S Millan, PhD^2*, Iléana Antony-Debré, PhD, PharmD^1* and Kimberly S Straley, BS²

¹Institut Gustave Roussy, Villejuif, France
²Auron Therapeutics, Newton, MA
³Institut Gustave Roussy, Villejuif, FRA

Suxing Liu^1*, Weimin Hu, PhD^2*, Dexiao Yang, MS^3*, Liang Han, MS^3*, Minghui Tong, PhD^3*, Yuna Yan, PhD^2*, Shek Ling Chan, PhD^2*, Zhiguo Xi, PhD^3*, Xuan Shi, MS^3* and Qiyue Hu, MS^2*

¹Beyang Therapeutics Co. Ltd., Edison, NJ
²Beyang Therapeutics Co. Ltd., Shanghai, China
³3D BioOptima, Suzhou, China

Britten K. Gordon, BS¹, Ethan C. Whipp, MSc^2*, Lianbo Yu, PhD^1*, Samon Benrashid, BS^1*, Andrew D. Mitchell, MS^1*, Alexander He, BS^1*, Jazmin Urrutia, BS^1*, Shrilekha Misra, PhD^1*, Alexander R. Marr, BS¹, Tzung-Huei Lai, DVM, PhD^1*, Naina Karnati^1*, Shanmugapriya Thangavadivel, PhD^3*, Kerry A. Rogers, MD⁴, Seema A. Bhat, MD^5*, Nicole R. Grieselhuber, MD, PhD⁶, Yi Chen, PhD^7*, Fenlai Tan, MD, PhD⁸, Stephen P. Anthony, DO⁹, Yu Chen, MD, PhD⁷, Deepa Sampath, PhD¹⁰, Rosa Lapalombella, PhD¹ and Jennifer A. Woyach, MD¹¹

¹The Ohio State University, Columbus, OH
²Comprehensive Cancer Center - Wexner Medical Center, The Ohio State University, Columbus, OH
³Division of Hematology, The Ohio State University, Dublin, OH
⁴Division of Hematology, The Ohio State University, Columbus, OH
⁵Division of Hematolopgy, The Ohio State University, Columbus, OH
⁶Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
⁷Newave Pharmaceutical Inc., Pleasanton, CA
⁸Guangzhou Lupeng Pharmaceutical Co. Ltd, Guangzhou, China
⁹Newave Pharmaceutical Inc., Colbert, WA
¹⁰Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Division of Hematology, Ohio State University Comprehensive Cancer Center, Columbus, OH

Min Lu¹, Lijuan Xia^2*, Yogesh Chutake^3*, Joyoti Dey, PhD, MPH^3* and Ronald Hoffman, MD⁴

¹The Tisch Cancer Institute, Division of Hematology & Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
²Tisch Cancer Institute, Department of Medicine, Division of Hematology/Oncology, Myeloproliferative Neoplasm-Research Consortium, Icahn School of Medicine at Mount Sinai, New York, NY
³Kymera Therapeutics, Watertown, MA
⁴Division of Hematology & Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Fernanda Marconi Roversi, PhD^1,2*, Maura Lima Pereira Bueno^2*, Samara de Sousa Mariano^3*, Fernanda Soares Niemann, MSc^2*, Adriana da Silva Santos Duarte, PhD^2*, Audrey Bastos^2*, Nádia Ghinelli Amôr, PhD^2*, Irene Santos, MSc^2*, Jose Andres Yunes^4*, Sandra Pinho, PhD⁵ and Sara Teresinha Olalla Saad, MD PhD²

¹Department of Surgery, Emory University (currently), Atlanta, GA
²Hematology and Transfusion Medicine Center, State University of Campinas – UNICAMP, Campinas, Brazil
³Centro Infantil Boldrini, Campinas, Brazil
⁴Boldrini Research Center, Campinas, Sao Paulo, Brazil
⁵Department of Pharmacology & Regenerative Medicine, University of Illinois at Chicago, Chicago, IL

Meng Liu^1*, Lei Zhang, PhD, MD^2*, Haojie Dong, PhD^2*, Xin He, MD^2*, Yang Li, MD^2,3*, Umesh Yadav^2*, Guido Marcucci^4,5 and Ling Li, PhD²

¹Department of Hematological Malignancies Translational Science, Beckman Research Institute, City of Hope National Medical Center, Monrovia, CA
²Department of Hematological Malignancies Translational Science, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA
³Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China
⁴Gehr Family Center for Leukemia Research, City of Hope, Duarte, CA
⁵Department of Hematologic Malignancies Translational Science, Duarte, CA

Nishat Iqbal, BSc, MSc^1*, Sandrine Jayne, PhD^1*, Harriet S. Walter, MD, PhD, MRCP^1*, Andrea Biondo, MD, PhD^2*, Martin Sims, PhD^2*, Maria Ahn, PhD^3* and Martin J.S. Dyer, MA, DPhil, FRCP, FRCPath^1*

¹The Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom
²Astex Pharmaceuticals, Cambridge, United Kingdom
³Astex Pharmaceuticals, Cambridge, GBR